The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
Open accessAbstract
Rheumatoid arthritis (RA) is a systemic poly-articular chronic autoimmune joint disease that mainly damages the hands and feet, which affects 0.5% to 1.0% of the population worldwide. With the sustained development of disease-modifying antirheumatic drugs (DMARDs), significant success has been achieved for preventing and relieving disease activity in RA patients. Unfortunately, some patients still show limited response to DMARDs, which puts forward new requirements for special targets and novel therapies. Understanding the pathogenetic roles of the various molecules in RA could facilitate discovery of potential therapeutic targets and approaches. In this review, both existing and emerging targets, including the proteins, small molecular metabolites, and epigenetic regulators related to RA, are discussed, with a focus on the mechanisms that result in inflammation and the development of new drugs for blocking the various modulators in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
11 retracted
Zheng, J., Zhu, L., In, I. I., Chen, Y., Jia, N., & Zhu, W. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105985 · Cited by 105
RetractedHao, L., Wan, Y., Xiao, J., Tang, Q., Deng, H., & Chen, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7299 · Cited by 44
RetractedWei, Q., Lv, F., Zhang, H., Wang, X., Geng, Q., Zhang, X., Li, T., Wang, S., Wang, Y., & Cui, Y. (2020) · Bioscience Reports · doi:10.1042/bsr20191136 · Cited by 40
RetractedHu, X., Tang, J., Hu, X., Bao, P., Deng, W., Wu, J., Liang, Y., Chen, Z., Gao, L., & Tang, Y. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.015 · Cited by 30
RetractedLi, D., Zhou, Q., Hu, G., & Wang, G. (2019) · Bioscience Reports · doi:10.1042/bsr20182500 · Cited by 22
RetractedQiang, J., Lv, T., Wu, Z., & Yang, X. (2019) · Bioscience Reports · doi:10.1042/bsr20190700 · Cited by 19
RetractedQu, Y., Zhang, Y., Wu, J., Jie, L., Deng, J., Zhao, D., & Yu, Q. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28390 · Cited by 18
RetractedWang, Z., Xiu, D., Jiang, J., & Liu, G. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23496 · Cited by 16
RetractedZhi, L.-Q., Zhong, Q., Ma, J.-B., Xiao, L., Yao, S.-X., & Wang, X. (2020) · PubMed · doi:10.26355/eurrev_202004_20985 · Cited by 13
RetractedHuang, Y., Chen, K., Yu, H., Chen, D., Deng, L., Zhang, Y., Xue, X., & Pan, X. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1717033 · Cited by 9
Self-citationRetractedZhao, W., Li, D., Su, Y., Zhao, H., Pang, W., Sun, Y., & Wu, S. (2019) · PubMed · Cited by 5
RetractedBombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Bartel, D. P. (2018) · Cell · doi:10.1016/j.cell.2018.03.006 · Cited by 3,751
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605
Smolen, J. S., Landewé, R. B. M., Bijlsma, J. W. J., Burmester, G. R., Dougados, M., Kerschbaumer, A., McInnes, I. B., Sepriano, A., van Vollenhoven, R. F., de Wit, M., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216655 · Cited by 2,710
Self-citationSmolen, J. S., Aletaha, D., Barton, A., Burmester, G. R., Emery, P., Firestein, G. S., Kavanaugh, A., McInnes, I. B., Solomon, D. H., Strand, V., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.1 · Cited by 2,445
Smolen, J. S., Landewé, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., Nam, J., Ramiro, S., Voshaar, M., van Vollenhoven, R., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210715 · Cited by 2,057
Self-citationMatrix Metalloproteinases: Role In Arthritis
Burrage, P. (2006) · Frontiers in Bioscience · doi:10.2741/1817 · Cited by 1,292
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Gender differences in autoimmune disease
Ngo, S. T., Steyn, F. J., & McCombe, P. A. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.004 · Cited by 1,074
Histone core modifications regulating nucleosome structure and dynamics
Tessarz, P., & Kouzarides, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3890 · Cited by 1,018
Historical insights into cytokines
Dinarello, C. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737772 · Cited by 926
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis.
Choy, E. (2012) · Rheumatology · doi:10.1093/rheumatology/kes113 · Cited by 816
Rheumatoid Arthritis: A Brief Overview of the Treatment
Bullock, J., Rizvi, S. A. A., Saleh, A. M., Ahmed, S. S., Do, D. P., Ansari, R. A., & Ahmed, J. (2018) · Medical Principles and Practice · doi:10.1159/000493390 · Cited by 776
Turesson, C., O'Fallon, W. M., Crowson, C. S., Gabriel, S. E., & Matteson, E. L. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.8.722 · Cited by 672
Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5
Huang, Y., Yan, J., Li, Q., Li, J., Gong, S., Zhou, H., Gan, J., Jiang, H., Jia, G.-F., Luo, C., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1276 · Cited by 662
Self-citationPlatelet-neutrophil-interactions: Linking hemostasis and inflammation
Zarbock, A., Polanowska-Grabowska, R. K., & Ley, K. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.06.001 · Cited by 651
Use of NSAIDs in treating patients with arthritis
Crofford, L. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4174 · Cited by 650
Little, C. B., Barai, A., Burkhardt, D., Smith, S. M., Fosang, A. J., Werb, Z., Shah, M., & Thompson, E. W. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25002 · Cited by 642
Messenger RNA modifications: Form, distribution, and function
Gilbert, W. V., Bell, T. A., & Schaening, C. (2016) · Science · doi:10.1126/science.aad8711 · Cited by 627
Raza, K., Falciani, F., Curnow, S. J., Ross, E. J., Lee, C.-Y., Akbar, A. N., Lord, J. M., Gordon, C., Buckley, C. D., & Salmon, M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1733 · Cited by 515
Yusuf‐Makagiansar, H., Anderson, M. E., Yakovleva, T. V., Murray, J. S., & Siahaan, T. J. (2002) · Medicinal Research Reviews · doi:10.1002/med.10001 · Cited by 408
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
Liu, Y., Yin, H., Zhao, M., & Lu, Q. (2014) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8402-y · Cited by 365
DNA methylome signature in rheumatoid arthritis
Nakano, K., Whitaker, J. W., Boyle, D. L., Wang, W., & Firestein, G. S. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201526 · Cited by 359
Dufton, N., Hannon, R., Brancaleone, V., Dalli, J., Patel, H. B., Gray, M., D’Acquisto, F., Buckingham, J. C., Perretti, M., & Flower, R. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903526 · Cited by 302
The role of the JAK/STAT signal pathway in rheumatoid arthritis
Malemud, C. J. (2018) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x18776224 · Cited by 302
The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis
Schett, G., Zwerina, J., & Firestein, G. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074278 · Cited by 271
Targeting interleukin‐15 in patients with rheumatoid arthritis: A proof‐of‐concept study
Baslund, B., Tvede, N., Danneskiold‐Samsoe, B., Larsson, P., Panayi, G., Petersen, J., Petersen, L. J., Beurskens, F. J. M., Schuurman, J., van de Winkel, J. G. J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21249 · Cited by 265
Haringman, J. J., Gerlag, D. M., Smeets, T. J. M., Baeten, D., van den Bosch, F., Bresnihan, B., Breedveld, F. C., Dinant, H. J., Legay, F., Gram, H., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21975 · Cited by 258
Matthys, P., Hatse, S., Vermeire, K., Wuyts, A., Bridger, G., Henson, G. W., De Clercq, E., Billiau, A., & Schols, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4686 · Cited by 251
Emery, P. E., Burmester, G. R., Bykerk, V. P., Combe, B. G., Fürst, D. E., Barré, E., Karyekar, C. S., Wong, D. A., & Huizinga, T. W. J. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206106 · Cited by 241
JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data
Harrington, R., Al Nokhatha, S. A., & Conway, R. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s219586 · Cited by 238
Vergunst, C. E., Gerlag, D. M., Lopatinskaya, L., Klareskog, L., Smith, M. D., van den Bosch, F., Dinant, H. J., Lee, Y., Wyant, T., Jacobson, E. W., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23591 · Cited by 236
Haringman, J. J., Smeets, T. J. M., Reinders-Blankert, P., & Tak, P. P. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.037176 · Cited by 227
Vincenti, M. P., Coon, C. I., & Brinckerhoff, C. E. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199811)41:11<1987::aid-art14>3.0.co;2-8 · Cited by 222
Brzustewicz, E., & Bryl, E. (2015) · Cytokine · doi:10.1016/j.cyto.2015.08.260 · Cited by 196
Therapeutic Anti-Cd3 Monoclonal Antibodies: From Bench to Bedside
Kuhn, C., & Weiner, H. L. (2016) · Immunotherapy · doi:10.2217/imt-2016-0049 · Cited by 195
Yellin, M., Paliienko, I., Balanescu, A., Ter‐Vartanian, S., Tseluyko, V., Xu, L., Tao, X., Cardarelli, P. M., LeBlanc, H., Nichol, G., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34330 · Cited by 194
CD19: a promising B cell target for rheumatoid arthritis
Tedder, T. F. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.184 · Cited by 187
METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-κ B Signaling Pathway
Wang, J., Yan, S., Lu, H., Wang, S., & Xu, D. (2019) · Mediators of Inflammation · doi:10.1155/2019/3120391 · Cited by 185
Prostaglandin E 2 constrains systemic inflammation through an innate lymphoid cell–IL-22 axis
Duffin, R., O’Connor, R. A., Crittenden, S., Forster, T., Yu, C., Zheng, X., Smyth, D., Robb, C. T., Rossi, F., Skouras, C., et al. (2016) · Science · doi:10.1126/science.aad9903 · Cited by 182
Leukotriene receptors as potential therapeutic targets
Yokomizo, T., Nakamura, M., & Shimizu, T. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97946 · Cited by 181
The anti-CD20 antibody rituximab reduces the Th17 cell response
van de Veerdonk, F. L., Lauwerys, B., Marijnissen, R. J., Timmermans, K., Di Padova, F., Koenders, M. I., Gutierrez-Roelens, I., Durez, P., Netea, M. G., van der Meer, J. W. M., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30314 · Cited by 180
Kawabata, T., Nishida, K., Takasugi, K., Ogawa, H., Sada, K., Kadota, Y., Inagaki, J., Hirohata, S., Ninomiya, Y., & Makino, H. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3071 · Cited by 169
Klein, K., Kabala, P. A., Grabiec, A. M., Gay, R. E., Kolling, C., Lin, L.-L., Gay, S., Tak, P. P., Prinjha, R. K., Ospelt, C., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205809 · Cited by 167
Mateen, S., Rehman, M. T., Shahzad, S., Naeem, S. S., Faizy, A. F., Khan, A. Q., Khan, M. S., Husain, F. M., & Moin, S. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.031 · Cited by 167
Epigenetics in rheumatoid arthritis
Klein, K., & Gay, S. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000128 · Cited by 165
Anti-TNF in rheumatoid arthritis: an overview
Radner, H., & Aletaha, D. (2015) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-015-0344-y · Cited by 163
Lee, A., Qiao, Y., Grigoriev, G., Chen, J., Park‐Min, K., Park, S. H., Ivashkiv, L. B., & Kalliolias, G. D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37853 · Cited by 163
Webber, J. P., Stone, T., Katilius, E., Smith, B. C., Gordon, B., Mason, M. D., Tabi, Z., Brewis, I. A., & Clayton, A. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.032136 · Cited by 162
Yang, J., Cheng, M., Gu, B., Wang, J., Yan, S., & Xu, D. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03038-z · Cited by 161
Bi, X., Guo, X. H., Mo, B. Y., Wang, M. L., Luo, X. Q., Chen, Y. X., Liu, F., Olsen, N., Pan, Y. F., & Zheng, S. G. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.024 · Cited by 159
Angiolilli, C., Kabala, P. A., Grabiec, A. M., van Baarsen, I. M., Ferguson, B. S., García, S., Malvar‐Fernández, B., McKinsey, T. A., Tak, P. P., Fossati, G., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-209064 · Cited by 158
Chemokines in joint disease: the key to inflammation?
Haringman, J. J., Ludikhuize, J., & Tak, P. P. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.020529 · Cited by 157
Chemokines and chemokine receptors in arthritis
Szekanecz, Z., Végvári, A., Szabo, Z., & Koch, A. E. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s53 · Cited by 156
Pathogenic role of the CXCL16–CXCR6 pathway in rheumatoid arthritis
Nanki, T., Shimaoka, T., Hayashida, K., Taniguchi, K., Yonehara, S., & Miyasaka, N. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21301 · Cited by 155
Combined Effects of IL-12 and IL-18 on the Induction of Collagen-Induced Arthritis
Leung, B. P. L., McInnes, I. B., Esfandiari, E., Wei, X., & Liew, F. Y. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6495 · Cited by 148
Park‐Min, K., Lim, E., Lee, M. J., Park, S. H., Γιαννοπούλου, Ε., Yarilina, A., van der Meulen, M. C. H., Zhao, B., Smithers, N. N., Witherington, J. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6418 · Cited by 146
Inhibition of Fractalkine Ameliorates Murine Collagen-Induced Arthritis
Nanki, T., Urasaki, Y., Imai, T., Nishimura, M., Muramoto, K., Kubota, T., & Miyasaka, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.7010 · Cited by 146
Lee, J.-H., Kim, B.-J., Jin, W. J., Kim, H., Ha, H., & Lee, Z. H. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1353-6 · Cited by 143
Heo, Y., Joo, Y.-B., Oh, H., Park, M., Heo, Y., Cho, M., Kwok, S., Ju, J., Park, K.-S., Cho, S., et al. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.10.006 · Cited by 137
Identification of a CXCR4 antagonist, a T140 analog, as an anti‐rheumatoid arthritis agent
Tamamura, H., Fujisawa, M., Hiramatsu, K., Mizumoto, M., Nakashima, H., Yamamoto, N., Otaka, A., & Fujii, N. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.05.056 · Cited by 137
DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
Ciechomska, M., Roszkowski, L., & Maśliński, W. (2019) · Cells · doi:10.3390/cells8090953 · Cited by 133
Augmentation of allergic inflammation in prostanoid IP receptor deficient mice
Takahashi, Y., Tokuoka, S., Masuda, T., Hirano, Y., Nagao, M., Tanaka, H., Inagaki, N., Narumiya, S., & Nagai, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704872 · Cited by 132
Choo, Q., Ho, P. C., Tanaka, Y., & Lin, H. (2010) · Rheumatology · doi:10.1093/rheumatology/keq108 · Cited by 130
Mateen, S., Moin, S., Shahzad, S., & Khan, A. Q. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178879 · Cited by 129
Targeting of Gr‐1+,CCR2+ monocytes in collagen‐induced arthritis
Brühl, H., Cihak, J., Plachý, J., Kunz‐Schughart, L. A., Niedermeier, M., Denzel, A., Gomez, M. R., Talke, Y., Luckow, B., Stangassinger, M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22854 · Cited by 127
Future therapeutic targets in rheumatoid arthritis?
Cheung, T. T., & McInnes, I. B. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0623-3 · Cited by 127
HDAC Inhibition in Rheumatoid Arthritis and Juvenile Idiopathic Arthritis
Vojinović, J., & Damjanov, N. S. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00030 · Cited by 121
Endres, M., Andreas, K., Kalwitz, G., Freymann, U., Neumann, K., Ringe, J., Sittinger, M., Häupl, T., & Kaps, C. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.08.003 · Cited by 120
CXCR5‐ and CCR7‐dependent lymphoid neogenesis in a murine model of chronic antigen‐induced arthritis
Wengner, A. M., Höpken, U. E., Petrow, P. K., Hartmann, S., Schurigt, U., Bräuer, R., & Lipp, M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22939 · Cited by 119
Yan, S., Wang, P., Wang, J., Yang, J., Lu, H., Jin, C., Cheng, M., & Xu, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02218 · Cited by 119
Amelioration of rat adjuvant‐induced arthritis by Met‐RANTES
Shahrara, S., Proudfoot, A. E. I., Woods, J. M., Ruth, J. H., Amin, M. A., Park, C. C., Haas, C. S., Pope, R. M., Haines, G. K., Zha, Y. Y., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21033 · Cited by 115
Seong, A., Yoo, J., Choi, K., Lee, M.-H., Lee, Y., Lee, J., Jun, W., Kim, S., & Yoon, H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.029 · Cited by 114
Talbot, J., Bianchini, F. J., Dcb., N., de Oliveira, R. D. R., Souto, F. O., Pinto, L. G., Peres, R. S., Silva, D., Almeida, S. C. L., Louzada‐Júnior, P., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39117 · Cited by 114
B-cells and their targeting in rheumatoid arthritis — Current concepts and future perspectives
Nakken, B., Munthe, L. A., Konttinen, Y. T., Sandberg, A. K., Szekanecz, Z., Alex, P., & Szodoray, P. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.06.010 · Cited by 113
Ruth, J. H., Haas, C. S., Park, C. C., Amin, M. A., Martinez, R. J., Haines, G. K., Shahrara, S., Campbell, P. L., & Koch, A. E. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21662 · Cited by 111
Grespan, R., Fukada, S. Y., Lemos, H. D. P., Vieira, S. M., Napimoga, M. H., Teixeira, M. M., Fraser, A. R., Liew, F. Y., McInnes, I. B., & Cunha, F. Q. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23597 · Cited by 110
Cribbs, A. P., Terlecki-Zaniewicz, S., Philpott, M., Baardman, J., Ahern, D., Lindow, M., Obad, S., Oerum, H., Sampey, B. P., Mander, P. K., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919893117 · Cited by 109
Najm, A., Masson, F., Preuss, P., Georges, S., Ory, B., Quillard, T., Sood, S., Goodyear, C. S., Veale, D. J., Fearon, U., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41441 · Cited by 108
Trenkmann, M., Brock, M., Gay, R. E., Kolling, C., Speich, R., Michel, B. A., Gay, S., & Huber, L. C. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143040 · Cited by 107
Inhibition of Monocyte Chemoattractant Protein-1 Ameliorates Rat Adjuvant-Induced Arthritis1
Shahrara, S., Proudfoot, A., Park, C. C., Volin, M., Haines, G., Woods, J., Aikens, C. H., Handel, T., & Pope, R. (2008) · Journal of Immunology · doi:10.4049/jimmunol.180.5.3447 · Cited by 106
CXCL 9 and CXCL 10 as Sensitive Markers of Disease Activity in Patients with Rheumatoid Arthritis
Kuan, W.-P., Tam, L., Wong, C. K., Ko, F. W. S., Li, T., ZHU, T. Y., & Li, E. K. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090769 · Cited by 105
Radstake, T. R. D. J., van der Voort, R., ten Brummelhuis, M., Malefijt, M. D. W., Looman, M., Figdor, C. G., van den Berg, W. B., Barrera, P., & Adema, G. J. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.017566 · Cited by 102
Miyabe, Y., Miyabe, C., Murooka, T. T., Kim, E. Y., Newton, G. A., Kim, N. D., Haribabu, B., Luscinskas, F. W., Mempel, T. R., & Luster, A. D. (2017) · Science Immunology · doi:10.1126/sciimmunol.aaj2195 · Cited by 101
Tak, P. P., Balanescu, A. R., Tseluyko, V., Bojin, S., Drescher, E., Dairaghi, D. J., Miao, S., Marchesin, V., Jaén, J. C., Schall, T. J., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-201605 · Cited by 100
Jenh, C., Cox, M. A., Cui, L., Reich, E., Sullivan, L., Chen, S., Kinsley, D., Qian, S., Kim, S. H., Rosenblum, S. B., et al. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-2 · Cited by 100
Vierboom, M., Zavodny, P. J., Chou, C., Tagat, J. R., Pugliese‐Sivo, C., Strizki, J., Steensma, R. W., McCombie, S. W., Paul, A., Remarque, E. J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20850 · Cited by 99
Blockade of the chemokine receptor CXCR2 ameliorates adjuvant‐induced arthritis in rats
Barsante, M. M., Cunha, T. M., Allegretti, M., Cattani, F., Policani, F., Bizzarri, C., Tafuri, W. L., Poole, S., Cunha, F. Q., Bertini, R., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707462 · Cited by 95
Adalimumab in the treatment of arthritis
Mease, P. J. (2007) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2007.3.1.133 · Cited by 95
Hartgring, S. A. Y., Willis, C. R., Alcorn, D., Nelson, L. J., Bijlsma, J. W. J., Lafeber, F. P. J. G., & van Roon, J. A. G. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27578 · Cited by 95
Yang, C., Luo, S., Hsieh, H., Chi, P., Lin, C., Wu, C., & Hsiao, L. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22153 · Cited by 95
Kinsey, S. G., Naidu, P. S., Cravatt, B. F., Dudley, D. T., & Lichtman, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.022 · Cited by 94
Xiao, Y., Liang, L., Huang, M., Qiu, Q., Zeng, S., Shi, M., Zou, Y., Ye, Y., Yang, X., & Xu, H. (2015) · Rheumatology · doi:10.1093/rheumatology/kev312 · Cited by 94
Bakheet, S. A., Ansari, M. A., Nadeem, A., Attia, S. M., Alhoshani, A., Gul, G., Alqahtani, Q. H., Albekairi, N. A., Ibrahim, K. E., & Ahmad, S. F. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109395 · Cited by 94
Chen, J., Liu, M., Luo, X., Peng, L., Zhao, Z., He, C., & He, Y. (2020) · Biomaterials Science · doi:10.1039/c9bm01761e · Cited by 94
Chen, Q., Muramoto, K., Masaaki, N., Ding, Y., Yang, H., Mackey, M., Li, W., Inoue, Y., Ackermann, K. E., Shirota, H., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00647.x · Cited by 93
Krausz, S., Boumans, M. J. H., Gerlag, D. M., Lufkin, J., van Kuijk, A. W. R., Bakker, A., de Boer, M., Lodde, B. M., Reedquist, K. A., Jacobson, E. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.34339 · Cited by 93
Wang, F., Chen, F., Gao, W.-B., Wang, H., Zhao, N., Xu, M., Gao, D.-Y., Yu, W., Yan, X., Zhao, J.-N., et al. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3247-4 · Cited by 93
Analysis of early changes in DNA methylation in synovial fibroblasts of RA patients before diagnosis
Karouzakis, E., Raza, K., Kolling, C., Buckley, C. D., Gay, S., Filer, A. D., & Ospelt, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-24240-2 · Cited by 93
Ramon, S., Bancos, S., Serhan, C. N., & Phipps, R. P. (2013) · European Journal of Immunology · doi:10.1002/eji.201343316 · Cited by 92
Angiolilli, C., Grabiec, A. M., Ferguson, B. S., Ospelt, C., Malvar‐Fernández, B., van Es, I. E., van Baarsen, L. G. M., Gay, S., McKinsey, T. A., Tak, P. P., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205635 · Cited by 88
Tak, P. P., Bacchi, M., & Bertolino, M. (2006) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03191127 · Cited by 87
Zhang, Y., Xu, Y., Sun, N., Liu, J., Chen, F.-F., Guan, X.-L., Li, A., Wang, F., Zhao, Q., Wang, H., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1129-4 · Cited by 87
Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networksin vivo
Amat, M., Benjamim, C. F., Williams, L. M., Prats, N., Terricabras, E., Beleta, J., Kunkel, S. L., & Godessart, N. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706912 · Cited by 86
Roles of CircRNAs in Autoimmune Diseases
Xia, X., Tang, X., & Wang, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00639 · Cited by 86
Vergunst, C. E., Gerlag, D. M., Moltke, L. L. V., Karol, M. D., Wyant, T. L., Chi, X., Matzkin, E., Leach, T. S., & Tak, P. P. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24978 · Cited by 85
Lebre, M. C., Vergunst, C. E., Choi, I. Y. K., Aarrass, S., Oliveira, A. S. F., Wyant, T. L., Horuk, R., Reedquist, K. A., & Tak, P. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021772 · Cited by 85
Meng, H.-Y., Chen, L.-Q., & Chen, L.-H. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-3159-y · Cited by 85
Wu, H., Zhou, X., Wang, X., Cheng, W., Hu, X., Wang, Y., Luo, B., Huang, W., & Gu, J. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15857 · Cited by 85
Anti-TNFα agents curb platelet activation in patients with rheumatoid arthritis
Manfredi, A. A., Baldini, M., Camera, M., Baldissera, E. M., Brambilla, M., Peretti, G. M., Maseri, A., Rovere, P. Q., Tremoli, E., Sabbadini, M. G., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208442 · Cited by 83
Isozaki, T., Arbab, A. S., Haas, C. S., Amin, M. A., Arendt, M. D., Koch, A. E., & Ruth, J. H. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37981 · Cited by 80
Li, G., Liu, Y., Meng, F., Xia, Z., Wu, X., Fang, Y., Zhang, C., Zhang, Y., & Liu, D. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14591 · Cited by 78
Gui, H., Liu, X., Wang, Z.-W., He, D.-Y., Su, D.-F., & Dai, S.-M. (2014) · Rheumatology · doi:10.1093/rheumatology/ket447 · Cited by 76
Oh, B. R., Suh, D., Bae, D., Ha, N., Choi, Y. I., Yoo, H. J., Park, J. K., Lee, E. Y., Lee, E. B., & Song, Y. W. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1357-2 · Cited by 76
Ramamoorthi, G., & Rasool, M. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.09.003 · Cited by 76
Stankovic, A., Slavić, V., Stamenkovic, B. N., Kamenov, B., Bojanovic, M., & Mitrovic, D. R. (2009) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657240 · Cited by 75
Hashimoto, A., Hayashi, I., Murakami, Y., Sato, Y., Kitasato, H., Matsushita, R., Iizuka, N., Urabe, K., Itoman, M., Hirohata, S., et al. (2007) · PubMed · Cited by 74
Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis
Armas‐González, E., Domínguez‐Luis, M. J., Díaz-Martín, A., Arce‐Franco, M., Castro‐Hernández, J., Danelon, G., Hernández-Hernández, V., Bustabad, S., Cantabrana, A., Uguccioni, M., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1611-2 · Cited by 74
Su, Y., Liu, Y., Ma, C., Guan, C., Ma, X., & Meng, S. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02248-1 · Cited by 72
Schafer, P. H., Kivitz, A., Ma, J., Korish, S., Sutherland, D., Li, L., Azaryan, A., Kosek, J., Adams, M., Capone, L., et al. (2019) · Rheumatology and Therapy · doi:10.1007/s40744-019-00182-7 · Cited by 71
Zhong, S., Ouyang, Q., Zhu, D., Huang, Q., Zhao, J., Fan, M., Cai, Y., & Yang, M. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.07.004 · Cited by 71
CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial
van Kuijk, A. W. R., Vergunst, C. E., Gerlag, D. M., Bresnihan, B., Gómez-Reino, J. J., Rouzier, R., Verschueren, P., van der Leij, C., Maas, M. M., Kraan, M. C., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.131235 · Cited by 70
Gao, B., Calhoun, K. H., & Fang, D. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2081 · Cited by 70
The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy
Moschovakis, G. L., Bubke, A., Friedrichsen, M., Ristenpart, J., Back, J. W., Falk, C. S., Kremmer, E., & Förster, R. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0056-5 · Cited by 70
Fleishaker, D. L., Meijide, J. A. G., Av, P., Kohen, M. D., Wang, X., Menon, S. S., Stock, T. C., Mebus, C. A., Goodrich, J. M., Mayer, H., et al. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3685 · Cited by 68
Gerlag, D. M., Hollis, S., Layton, M., Vencovský, J., Szekanecz, Z., Braddock, M., Tak, P. P., & ESCAPE Study Group (2010) · Arthritis & Rheumatism · doi:10.1002/art.27652 · Cited by 68
Khatami, G., Mir-Nasseri, M., Seyghali, F., Allah-Verdi, B., & Yourdkhani, F. (2010) · PubMed Central · Cited by 68
N-Acyl Amino Acids (Elmiric Acids): Endogenous Signaling Molecules with Therapeutic Potential
BURSTEIN, S. H. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.110841 · Cited by 68
Huang, Z., Xing, S., Liu, M., Deng, W., Wang, Y., Huang, Z., Huang, Y., Huang, X., Wu, C.-W., Guo, X., et al. (2019) · Bioscience Reports · doi:10.1042/bsr20182192 · Cited by 66
Self-citationZhang, L., Zhang, X., Wu, P., Li, H., Jin, S.-W., Zhou, X.-Y., Li, Y., Ye, D.-Y., Chen, B., & Wan, J. (2008) · Inflammation Research · doi:10.1007/s00011-007-7141-z · Cited by 65
T cell specific Cxcr5 deficiency prevents rheumatoid arthritis
Moschovakis, G. L., Bubke, A., Friedrichsen, M., Falk, C. S., Feederle, R., & Förster, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-08935-6 · Cited by 65
Yuan, M., Wang, S., Li-jie, Y., Qu, B., Xu, L., Liu, L., Sun, H., Li, C., Shi, Y., & Liu, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186795 · Cited by 64
Rao, Y., Fang, Y., Tan, W., Liu, D., Pang, Y., Wu, X., Zhang, C., & Li, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.551681 · Cited by 64
Wen, J., Liu, J., Zhang, P., Jiang, H., Xin, L., Wan, L., Sun, Y., Huang, D., Sun, Y., Long, Y., et al. (2020) · Bioscience Reports · doi:10.1042/bsr20193160 · Cited by 63
Chen, Z., Kim, S.-J., Essani, A. B., Volin, M. V., Vila, O. M., Swedler, W. I., Arami, S., Volkov, S., Sardin, L. V., Sweiss, N., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204530 · Cited by 62
Haas, C. S., Amin, M. A., Ruth, J. H., Allen-Petersen, B. L., Ahmed, S., Pákozdi, A., Woods, J. M., Shahrara, S., & Koch, A. E. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22823 · Cited by 60
Zayed, N., Afif, H., Chabane, N., Endam, L. M., Benderdour, M., Martel‐Pelletier, J., Pelletier, J., Motiani, R. K., Trebak, M., Duval, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23958 · Cited by 59
Li, B., Li, N., Zhang, L., Li, K., Xie, Y., Xue, M., & Zheng, Z. (2018) · Journal of Immunology Research · doi:10.1155/2018/9412387 · Cited by 59
Dairaghi, D. J., Zhang, P., Wang, Y., Seitz, L. C., Johnson, D. A., Miao, S., Ertl, L. S., Zeng, Y., Powers, J. P., Pennell, A. M. K., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.33 · Cited by 58
Long noncoding RNA MEG3 regulates rheumatoid arthritis by targeting NLRC5
Liu, Y., Yang, L., Xu, Q., Lü, X., Ma, T., Huang, C., & Li, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28126 · Cited by 58
Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis
Wiese, M. D., Manning-Bennett, A. T., & Abuhelwa, A. Y. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1752660 · Cited by 58
Wang, Y., Hou, L., Yuan, X., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01975 · Cited by 58
Gullick, N., Abozaid, H. S. M., Jayaraj, D. M., Evans, H. G., Scott, D. L., Choy, E., & Taams, L. S. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12167 · Cited by 57
Rückert, R., Brandt, K., Ernst, M., Marienfeld, K., Csernok, E., Metzler, C., Budagian, V., Bulanova, E., Paus, R., & Bulfone‐Paus, S. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02878.x · Cited by 56
Santos-Savio, A., Diaz, A. C. M., Chico-Capote, A., Miranda-Navarro, J., Alvarez, Y. R., Bringas-Pérez, R., del Toro, M. E., & Nieto, G. G. G. (2015) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-015-0516-3 · Cited by 56
Park, J. K., Jang, Y. J., Oh, B. R., Shin, J., Bae, D., Ha, N., Choi, Y. I., Youn, G. S., Park, J., Lee, E. Y., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02258-0 · Cited by 56
Díaz‐González, F., Alten, R. H.-E., Bensen, W., Brown, J. P., Sibley, J. T., Dougados, M., Bombardieri, S., Durez, P., Ortiz, P., de-Miquel, G., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062554 · Cited by 55
Liu, D., Fang, Y., Rao, Y., Tan, W., Zhou, W., Wu, X., Zhang, C., Zhang, Y., Liu, Y., Sunagawa, M., et al. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01882-2 · Cited by 55
Cook, A. D., Louis, C., Robinson, M. J., Saleh, R., Sleeman, M. A., & Hamilton, J. A. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1185-9 · Cited by 52
Jiang, H., Cao, K., Chang, F., Cui, X., Ma, Y., & Liu, J. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s296006 · Cited by 52
Crotti, C., Agape, E., Becciolini, A., Biggioggero, M., & Favalli, E. G. (2019) · Drugs · doi:10.1007/s40265-019-01192-z · Cited by 51
Fechtner, S., Singh, A., Srivastava, I., Szlenk, C. T., Muench, T. R., Natesan, S., & Ahmed, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01027 · Cited by 50
MicroRNA‑34a‑3p inhibits proliferation of rheumatoid arthritis fibroblast‑like synoviocytes
Hou, C., Wang, D., & Zhang, L. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10516 · Cited by 50
Critical Role of LTB4/BLT1 in IL-23–Induced Synovial Inflammation and Osteoclastogenesis via NF-κB
Bouchareychas, L., Grössinger, E. M., Kang, M., Qiu, H., & Adamopoulos, I. E. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601346 · Cited by 48
ElAtta, A. S. A., Ali, Y. B. M., Bassyouni, I. H., & Talaat, R. M. (2018) · Clinical and Experimental Medicine · doi:10.1007/s10238-018-0524-3 · Cited by 48
Wang, Y., Feng, T., Duan, S., Shi, Y., Li, S., Zhang, X., & Zhang, L. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8330 · Cited by 48
Hong, K.-H., Cho, M. L., Min, S.-Y., Shin, Y.-J., Yoo, S.-A., Choi, J.-J., Kim, W.-U., Song, S.-W., & Cho, C.-S. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03295.x · Cited by 47
Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis
Zhou, G., Sun, X., Qin, Q., Lv, J., Cai, Y., Wang, M., Mu, R., Lan, H.-Y., & Wang, Q. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02537 · Cited by 47
Cai, Y., Jiang, C., Zhu, J., Xu, K., Ren, X., Xu, L., Hu, P., Wang, B., Yuan, Q., Guo, Y., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1920-0 · Cited by 47
Caselli, G., Bonazzi, A., Lanza, M., Ferrari, F., Maggioni, D., Ferioli, C., Giambelli, R., Comi, E., Zerbi, S., Perrella, M., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1537-8 · Cited by 46
Yang, X., Li, J., Wu, Y., Ni, B., & Zhang, B. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1674004 · Cited by 46
Luo, Q., Liu, J., Fu, B., Zhang, L., Guo, Y., Huang, Z., & Li, J. (2019) · Disease Markers · doi:10.1155/2019/2073139 · Cited by 46
LncRNA GAS5 alleviates rheumatoid arthritis through regulating miR-222-3p/Sirt1 signalling axis
Yang, Z., Lin, S.-D., Zhan, F., Liu, Y., & Zhan, Y.-W. (2021) · Autoimmunity · doi:10.1080/08916934.2020.1846183 · Cited by 46
Yang, B., Ge, Y. L., Zhou, Y., Wang, J., Xie, X., Li, S., Tang, M., Xu, L., & Tian, J. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3386 · Cited by 45
Li, G., Tan, W., Fang, Y., Wu, X., Zhou, W., Zhang, C., Zhang, Y., Liu, Y., Jiu, G., & Liu, D. (2019) · Aging · doi:10.18632/aging.101986 · Cited by 45
Yang, X., Li, S., Zhao, Y., Li, S., Zhao, T., Tai, Y., Zhang, B., Wang, X., Wang, C., Chen, J., et al. (2019) · Cells · doi:10.3390/cells8121596 · Cited by 45
An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium
Rump, L. J. M., Mattey, D. L., Kehoe, O., & Middleton, J. (2017) · Cytokine · doi:10.1016/j.cyto.2017.05.023 · Cited by 44
Long non-coding RNA GAS5 suppresses rheumatoid arthritis progression via miR-128-3p/HDAC4 axis
Peng, T., Ji, D., & Jiang, Y. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04098-1 · Cited by 44
Kim, N., Lannan, K. L., Thatcher, T. H., Pollock, S. J., Woeller, C. F., & Phipps, R. P. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700503 · Cited by 42
Ahmed, S., Riegsecker, S., Beamer, M. A., Rahman, A., Bellini, J. V., Bhansali, P. R., & Tillekeratne, L. M. V. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.04.014 · Cited by 42
Prostaglandin D2 regulates joint inflammation and destruction in murine collagen‐induced arthritis
Maicas, N., Ibáñez, L., Alcaraz, M. J., Úbeda, A., & Ferrándiz, M. L. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30656 · Cited by 41
Yu, S., Lü, Y., Zong, M., Tan, Q., & Fan, L. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1861-7 · Cited by 41
MicroRNA-27b-3p inhibits apoptosis of chondrocyte in rheumatoid arthritis by targeting HIPK2
Zhou, Y., Li, S., Chen, P., Yang, B., Yang, J., Liu, R., Li, J., & Xia, D. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1607362 · Cited by 41
Pitaksalee, R., Burska, A., Ajaib, S., Rogers, J. H., Parmar, R., Mydlova, K., Xie, X., Droop, A., Nijjar, J. S., Chambers, P. A., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00837-1 · Cited by 41
Tang, J., Yi, S., & Liu, Y. (2020) · Human Cell · doi:10.1007/s13577-020-00419-6 · Cited by 41
The roles of small‐molecule inflammatory mediators in rheumatoid arthritis
Cheng, Q., Wu, H., & Du, Y. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12982 · Cited by 40
Woo, S. J., Lee, S., Lim, H. S., Hah, Y., Jung, I. D., Park, Y., Kim, H. O., Cheon, Y., Jeon, M.-G., Jang, K. Y., et al. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.124 · Cited by 39
Long noncoding RNAs expression profile and functional networks in rheumatoid arthritis
Xu, D., Jiang, Y., Yang, L., Hou, X., Wang, J., Gu, W., Wang, X., Liu, L., Zhang, J., & Lu, H. (2017) · Oncotarget · doi:10.18632/oncotarget.20036 · Cited by 39
for the Hong Kong Society of Rheumatology, Ho, C. T. K., Mok, C. C., Cheung, T. T., Kwok, K. Y., & Yip, R. M.-L. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04761-5 · Cited by 39
Wang, W., Guo, P., Chen, M., Chen, D., Cheng, Y., & He, L. (2019) · Bioscience Reports · doi:10.1042/bsr20191900 · Cited by 39
Reyes‐Pérez, I. V., Sánchez‐Hernández, P. E., Muñóz-Valle, J. F., Martínez-Bonilla, G., García‐Iglesias, T., González-Díaz, V., García‐Arellano, S., Cerpa‐Cruz, S., Polanco-Cruz, J., & Ramírez‐Dueñas, M. G. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04681-4 · Cited by 38
Panezai, J., Ali, A., Ghaffar, A., Benchimol, D., Altamash, M., Klinge, B., Engström, P.-E., & Larsson, A. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155117 · Cited by 37
Targeting cell migration in rheumatoid arthritis
Asquith, D. L., Bryce, S. A., & Nibbs, R. J. B. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000150 · Cited by 37
Ruth, J. H., Park, C. C., Amin, M. A., Lesch, C. A., Marotte, H., Shahrara, S., & Koch, A. E. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3055 · Cited by 37
Sun, L., Tu, J., Liu, C., Pan, A., Xia, X., & Chen, X. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00666-6 · Cited by 37
Self-citationLuo, Q., Zeng, L., Zeng, L., Rao, J., Zhang, L., Guo, Y., Huang, Z., & Li, J. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4498 · Cited by 37
LncRNA H19 aggravates TNF ‐α‐induced inflammatory injury via TAK1 pathway in MH7A cells
Yang, J., Li, Y., Wang, L., Zhang, Z., Li, Z., & Jia, Q. (2020) · BioFactors · doi:10.1002/biof.1659 · Cited by 37
Self-citationZhao, F., Dong, J., Guo, J., & Bi, L. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112136 · Cited by 37
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Management of Rheumatoid Arthritis: An Overview
Radu, A.-F., & Bungau, S. G. (2021) · Cells · doi:10.3390/cells10112857 · Cited by 1,089
Metadata
- Authors
- Huang, J., Fu, X., Chen, X., Li, Z., Huang, Y., & Liang, C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-07-09
- Volume
- 12
- Pages
- 686155-686155
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3181834541
- Cited by
- 340
- References
- 250
- FWCI
- 32.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.